Medicaid Projection Tool
To illustrate the potential clinical and economic benefits of improved medication adherence among patients with diabetes covered by Medicaid in each state, the Medicaid Diabetes Adherence Online Tool was developed to help visualize the simulated 10-year outcomes from the following three hypothetical scenarios using the Disease Prevention Microsimulation Mode:
- Baseline scenario: This scenario forecasts incidence of diabetes complications and medical expenditures given current levels of anti-diabetes medication adherence among Medicaid patients diagnosed with diabetes in each state.
- Modest improvement scenario: This scenario forecasts future incidence and medical expenditures associated with a 20% increase in states’ anti-diabetes medication adherence rate.
- Aggressive improvement scenario: This scenario forecasts future incidence and medical expenditures associated with a 40% increase in states’ anti-diabetes medication adherence rate.
The tool is formatted for use on a desktop device only.
Projecting benefit of improved adherence to antidiabetic medication among Medicaid beneficiaries – a visual comparison across 50 states and Washington DC
Members
More than 30 million people in the United States are living with diabetes, and about 5 million of them are covered by Medicaid. Individuals living in poverty are more likely to develop diabetes and related complications such as cardiovascular disease, kidney disease, blindness, nerve damage, and amputation.
These serious conditions contribute to early mortality and create a substantial economic burden, including missed days of work or loss of productivity. As the largest public source of insurance for the low-income population, Medicaid program spent more than $25 billion on diabetes-related treatment in 2013.
FeaturedResource
Medicaid
Medicaid provides health coverage for low-income and disabled individuals, and is jointly funded by state and federal governments.
